Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70518-4090

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure001)

Structure (Structure001)
Chemical structure of Metoprolol Succinate, depicting its molecular arrangement with hydroxyl groups, methoxy groups attached to a benzene ring, and succinate moiety.*
FDA Label Image

Figure (Figure001)

Figure (Figure001)
A forest plot depicting the results for subgroups in the MERIT-HE study. The chart shows relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization (time to first event), and total mortality or hospitalization for heart failure (time to first event). Data are stratified by demographic and clinical subgroups including geographic location, NYHA class, ejection fraction, ischemic etiology, sex, race, prior myocardial infarction, diabetes status, hypertension history, and heart rate.*
FDA Label Image

Mm1 (Metoprolol Succinate 25mg 70518 4090 00)

Mm1 (Metoprolol Succinate 25mg 70518 4090 00)
This label is for Metoprolol Succinate extended-release tablets, 25 mg strength, in a package of 5 tablets. The label shows the NDC 70518-4090-00 and indicates the product is repackaged by RemedyRepack Inc. Storage instructions specify temperature ranges and caution to keep out of children's reach. Manufacturer information for Oryza Pharmaceuticals Inc. is included.*
FDA Label Image

Mm2 (Metoprolol Succinate 25mg 70518 4090 01)

Mm2 (Metoprolol Succinate 25mg 70518 4090 01)
Metoprolol Succinate 25 mg extended-release tablets packaging label showing a quantity of 30 tablets. The label includes storage instructions to protect from moisture and lists RemedyRepack Inc. as the repackager. Manufacturer is Oryza Pharmaceuticals Inc., Coral Springs, FL. The label includes the NDC 70518-4090-01 and notes 'RX ONLY.'*
FDA Label Image

Mm3 (Metoprolol Succinate 25mg 70518 4090 02)

Mm3 (Metoprolol Succinate 25mg 70518 4090 02)
Metoprolol Succinate 25 mg extended-release tablet label showing a quantity of 90 tablets. The label includes storage instructions to protect from moisture and temperature guidelines. It is repackaged by RemedyRepack Inc. in Indiana, PA. Manufacturer information lists Oryza Pharmaceuticals Inc. in Coral Springs, FL. The label includes the NDC number 70518-4090-02 and other regulatory details.*
FDA Label Image

Mm4 (Metoprolol Succinate 25mg 70518 4090 03)

Mm4 (Metoprolol Succinate 25mg 70518 4090 03)
Metoprolol Succinate 25 mg extended-release oral tablets, packaged in a quantity of 30 tablets. The label includes the NDC number 70518-4090-03 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufacturer is Oryza Pharmaceuticals Inc., Coral Springs, FL. The label advises usual dosage per insert, storage temperature, and keeping medication out of children's reach.*
FDA Label Image

Mm5 (Metoprolol Succinate 25mg 70518 4090 04)

Mm5 (Metoprolol Succinate 25mg 70518 4090 04)
Metoprolol Succinate 25 mg extended-release tablet label showing 90 tablets per package. The label indicates the product is repackaged by RemedyRepack Inc., Indiana, PA. The NDC listed is 70518-4090-04 and includes storage instructions and manufacturer information for Oryza Pharmaceuticals Inc., Coral Springs, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.